Uni-Bio Science Group Limited (0690.HK)
Develops and sells pharmaceutical drugs for bone disease, infections, and wound healing in China and Hong Kong.
0.08-0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-46.0%
The outlook
Uni-Bio Science Group trades at 0.081, well below both its 50- and 200-day moving averages and sitting near the lower end of its 52-week range. The stock carries a low trailing P/E of 4.0, though analyst coverage appears thin. Current data reflects a bearish lean with minimal upward momentum.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Market cap
$483.7M
52-wk high
0.17
52-wk low
0.08
50-day avg
0.09
200-day avg
0.11
Trailing P/E
4.0